Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histone Deacetylase Inhibitor”

189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 189 results

Early research (Phase 1)Study completedNCT00412997
What this trial is testing

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

Who this might be right for
TumorsCutaneous T-Cell Lymphoma
Novartis 14
Testing effectiveness (Phase 2)Study completedNCT03820596
What this trial is testing

Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL

Who this might be right for
Safety and Efficacy
Huiqiang Huang 40
Large-scale testing (Phase 3)UnknownNCT03564470
What this trial is testing

Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

Who this might be right for
LeukemiaLeukemia, AcuteLeukemia, Lymphoblastic+1 more
Nanfang Hospital, Southern Medical University 120
Early research (Phase 1)Study completedNCT01567709
What this trial is testing

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT00496444
What this trial is testing

Azacytidine and Valproic Acid in Patients With Advanced Cancers

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Ended earlyNCT00524667
What this trial is testing

HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
CancerCare Manitoba 6
Testing effectiveness (Phase 2)Looking for participantsNCT06220487
What this trial is testing

A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL

Who this might be right for
Acute Lymphoblastic LeukemiaPhiladelphia ChromosomePhiladelphia-Positive ALL+2 more
Nanfang Hospital, Southern Medical University 67
Testing effectiveness (Phase 2)Study completedNCT00365599
What this trial is testing

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 43
Testing effectiveness (Phase 2)UnknownNCT03373019
What this trial is testing

Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
ChidamideLymphoma, B-CellLymphoma, Large B-Cell, Diffuse+13 more
Fudan University 63
Testing effectiveness (Phase 2)Study completedNCT01486277
What this trial is testing

The Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Cutaneous
Janssen Research & Development, LLC 26
Testing effectiveness (Phase 2)Study completedNCT01045538
What this trial is testing

Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP

Who this might be right for
Gastric CancerHistone Deacetylase Inhibitor
Asan Medical Center 45
Early research (Phase 1)Active Not RecruitingNCT01087554
What this trial is testing

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 249
Early research (Phase 1)Looking for participantsNCT01245179
What this trial is testing

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Abdullah Kutlar 18
Testing effectiveness (Phase 2)Study completedNCT00792467
What this trial is testing

Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma

Who this might be right for
Hodgkin's Lymphoma
Italfarmaco 24
Early research (Phase 1)Study completedNCT00741234
What this trial is testing

A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine

Who this might be right for
Solid TumorsHematologic MalignanciesMyelodysplastic Syndrome
S*BIO 85
Testing effectiveness (Phase 2)WithdrawnNCT02756663
What this trial is testing

Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals
Early research (Phase 1)Ended earlyNCT00437957
What this trial is testing

Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases

Who this might be right for
Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute 10
Early research (Phase 1)Study completedNCT04447027
What this trial is testing

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Who this might be right for
Cutaneous T-Cell LymphomaMature T-cell MalignanciesPeripheral T-Cell Lymphoma+1 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)UnknownNCT02213861
What this trial is testing

Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T-Cell Lymphoma (CTCL)
TetraLogic Pharmaceuticals 60
Testing effectiveness (Phase 2)Ended earlyNCT00083473
What this trial is testing

A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, ChronicLymphoma, Small Lymphocytic
Titan Pharmaceuticals 28
Next Page